Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Interest Expenses (2020 - 2025)

Historic Interest Expenses for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $6.8 million.

  • Maravai Lifesciences Holdings' Interest Expenses fell 4980.2% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year decrease of 3884.68%. This contributed to the annual value of $47.7 million for FY2024, which is 393.97% up from last year.
  • Maravai Lifesciences Holdings' Interest Expenses amounted to $6.8 million in Q3 2025, which was down 4980.2% from $6.8 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Interest Expenses high stood at $15.4 million for Q4 2023, and its period low was $2.7 million during Q1 2022.
  • Its 5-year average for Interest Expenses is $8.7 million, with a median of $7.7 million in 2021.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Interest Expenses tumbled by 6629.55% in 2022, and later surged by 34418.17% in 2023.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Interest Expenses stood at $7.0 million in 2021, then surged by 44.97% to $10.2 million in 2022, then soared by 51.28% to $15.4 million in 2023, then dropped by 26.86% to $11.3 million in 2024, then tumbled by 39.23% to $6.8 million in 2025.
  • Its Interest Expenses was $6.8 million in Q3 2025, compared to $6.8 million in Q2 2025 and $6.8 million in Q1 2025.